SEC Form 4 · accession 0001144204-15-012900
Celator Pharmaceuticals Inc · CPXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Thomas Jackson
Officer — Chief Executive Officer · Director
Period of report
Feb 25, 2015
Accepted (ET)
Feb 27, 2015 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001327467
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2015 | A | 22,593 | $0.00 | A | 35,593 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option, Right to BuyF1 | $2.79 | Feb 25, 2015 | A | 175,000 | A | — | Feb 25, 2025 | Common Stock | 175,000 | 175,000 | D |
Explanation of responses
- F1The options vest as follows: (i) 43,750 options vest on February 25, 2016; (ii) 11 consecutive quarterly installments of 10,938 options vest on the 25th day of each May, August, November and February, beginning May 25, 2016 and continuing through November 25, 2018 and (iii) 10,932 options vest on February 25, 2019.